UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 8, 2025
Accession Number:
0001641172-25-002375
Submission Type:
POS AM
CIK:
0001595353
Company Name:
Galmed Pharmaceuticals Ltd.
File Number:
333-282753